Enrica Capelletto
0000-0003-2070-9335
3 papers found
Refreshing results…
Niraparib plus Dostarlimab in Pleural Mesothelioma or Non–Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial
Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial
Missing publications? Search for publications with a matching author name.